These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12244650

  • 21. Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome.
    Brown MM, Brown GC, Brown HC, Peet J, Roth Z.
    Arch Ophthalmol; 2009 Feb; 127(2):146-52. PubMed ID: 19204231
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye.
    Roberts CW, Carniglia PE, Brazzo BG.
    Cornea; 2007 Aug; 26(7):805-9. PubMed ID: 17667613
    [Abstract] [Full Text] [Related]

  • 25. Real-world utilization patterns of cyclosporine ophthalmic emulsion 0.05% within managed care.
    Chiang TH, Walt JG, McMahon JP, Mansfield JE, Simonyi S.
    Can J Clin Pharmacol; 2007 Aug; 14(2):e240-5. PubMed ID: 17622671
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
    Willen CM, McGwin G, Liu B, Owsley C, Rosenstiel C.
    Eye Contact Lens; 2008 Jan; 34(1):43-5. PubMed ID: 18180683
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Clinical review: topical ophthalmic use of cyclosporin A.
    Utine CA, Stern M, Akpek EK.
    Ocul Immunol Inflamm; 2010 Oct; 18(5):352-61. PubMed ID: 20735287
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cyclosporine 0.05% ophthalmic emulsion for the treatment of radiation-associated dry eye in children.
    Hoehn ME, Kelly SR, Wilson MW, Walton RC.
    Pediatr Blood Cancer; 2013 Jul; 60(7):E35-7. PubMed ID: 23335290
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis.
    Akpek EK, Dart JK, Watson S, Christen W, Dursun D, Yoo S, O'Brien TP, Schein OD, Gottsch JD.
    Ophthalmology; 2004 Mar; 111(3):476-82. PubMed ID: 15019322
    [Abstract] [Full Text] [Related]

  • 35. [Immunological phenomenons in the pathology of the tear film. Is cyclosporine the turn point in the Sjögren's syndrome treatment? Preliminary report].
    Kujawa A, Rózycki R.
    Klin Oczna; 2004 Mar; 106(3 Suppl):489-91. PubMed ID: 15636245
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Corneal complications after hematopoietic stem cell transplantation].
    Mittelviefhaus H, Auw-Hädrich C.
    Ophthalmologe; 2003 Mar; 100(3):222-9. PubMed ID: 12640552
    [Abstract] [Full Text] [Related]

  • 38. [0.05% cyclosporine a for treatment of chronic severe ocular surface disease].
    Nochez Y, Denoyer A, Pisella PJ.
    Can J Ophthalmol; 2009 Aug; 44(4):406-11. PubMed ID: 19606161
    [Abstract] [Full Text] [Related]

  • 39. Ketorolac during the induction phase of cyclosporin-A therapy.
    Schechter BA.
    J Ocul Pharmacol Ther; 2006 Apr; 22(2):150-4. PubMed ID: 16722802
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of cyclosporine 0.05% eye drops in Stevens Johnson syndrome with chronic dry eye.
    Prabhasawat P, Tesavibul N, Karnchanachetanee C, Kasemson S.
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):372-7. PubMed ID: 23289903
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.